TNF-related apoptosis-inducing ligand level in Alzheimer's disease

Neurological Sciences

Volumn 30, Issue 3, 2009, Pages 263-267

  Genc, Sermin ^a   Egrilmez, Mehtap Yuksel ^a   Yaka, Erdem ^a   Cavdar, Zahide ^a   Iyilikci, Leyla ^a   Yener, Gorsev ^a   Genc, Kursad ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Brain; Microglia; Neurodegeneration; Neuron; TRAIL

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; REFERENCE VALUES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 67349206984     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0047-5     Document Type: Article

References (23)

1. Selkoe DJ (1994) Alzheimer's disease: A central role for amyloid. J Neuropathol Expl Neurol 53:438-447
2. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259
3. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105
4. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II: Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
5. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (IV-TR). 4th edn, text revised, Washington DC
6. McKhann G, Drachman DA, Folstein M, Katzman R, Price DL, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease - report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
7. Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L (2007) Altered plasma cytokine levels in Alzheimer's disease: Correlation with the disease progression. Immunol Lett 114(1):46-51
8. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
9. Aktas O, Schulze-Topphoff U, Zipp F (2007) The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci 12:2912-2921
10. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U, Zipp F (2000) Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356:827-828
11. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, Choi IH (1999) Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol 162:1889-1895
12. Genc S, Kizildag S, Ates H, Genc K, Atabey N (2003) LPS and IFN γ upregulate TNF related Apoptosis Inducing Ligand (TRAIL) expression on murine microglial cells. Immunol Lett 85:271-274
13. Wu M, Das A, Tan Y, Zhu C, Cui T, Wong MC (2000) Induction of apoptosis in glioma cell lines by TRAIL/Apo-2l. J Neurosci Res 61:464-470
14. Uberti D, Cantarella G, Facchetti F, Cafici A, Grasso G, Bernardini R, Memo M (2004) TRAIL is expressed in the brain cells of Alzheimer's disease patients. Neuroreport 15:579-581
15. Cantarella G, Uberti D, Carsana T, Lombardo G, Bernardini R, Memo M (2003) Neutralization of TRAIL death pathway protects human neuronal cell line from β-amyloid toxicity. Cell Death Differ 10:134-141
16. Uberti D, Ferrari-Toninelli G, Bonini SA, Sarnico I, Benarese M, Pizzi M, Benussi L, Ghidoni R, Binetti G, Spano P, Facchetti F, Memo M (2007) Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. Neuropsychopharmacology 32:872-880
17. Dörr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F (2002) Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci 22:RC209
18. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM (1999) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809-3817
19. Lee J, Shin JS, Park JY, Kwon D, Choi SJ, Kim SJ, Choi IH (2003) p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes. J Neurosci Res 74:884-890
20. Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttilä T (2009) Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging 30(2):198-209
21. Blass JP, Zemcov A (1984) Alzheimer's disease. A metabolic systems degeneration? Neurochem Pathol 2:103-114
22. Scott RB (1993) Extraneuronal manifestations of Alzheimer's disease. J Am Geriatr Soc 41:268-276
23. Sala G, Galimberti G, Canevari C, Raggi ME, Isella V, Facheris M, Appollonio I, Ferrarese C (2003) Peripheral cytokine release in Alzheimer patients: Correlation with disease severity. Neurobiol Aging 24:909-914